TMDIF — Titan Medical Share Price
0.000.00%
Last trade - 00:00- $4.14m
- $1.34m
- $17.63m
- 25
- 21
- 27
- 14
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.52 | ||
| Price to Tang. Book | 1.52 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.36 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -172.86% | ||
| Return on Equity | -96.22% | ||
| Operating Margin | -604.84% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 20 | 20.09 | n/a | 17.63 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Titan Medical Inc. is a Canada-based medical technology company. The Company has developed a patent portfolio related to the enhancement of robotic assisted surgery (RAS), including through a single access point. The Company is focused on evaluating new opportunities to license its intellectual property, while reviewing and evaluating further strategic alternatives for the business, including a corporate sale, merger or other business combination, a sale of all or a portion of the Company’s assets, strategic investment or other significant transaction.
Directors
- Paul Cataford CHM (57)
- Stephen Lemieux CFO
- Perry Genova SVP
- Chien Huang VFN
- Chris Seibert VPR
- Kristen Galfetti VPR
- Tammy Carrea VPR
- Anthony Giovinazzo LED
- Heather Knight IND
- Cary Vance IND (51)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- July 28th, 2008
- Public Since
- April 28th, 2008
- No. of Employees
- 4
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 114,039,850
- Address
- 76 Berkeley Street, TORONTO, M5A 2W7
- Web
- https://www.titanmedicalinc.com/
- Phone
- +1 4165487522
- Auditors
- MNP LLP
Upcoming Events for TMDIF
Q4 2024 Titan Medical Inc Earnings Release
Similar to TMDIF
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
What is the Titan Medical share price?
As of Today at 23:43 UTC, shares in Titan Medical are trading at $0.03. This share price information is delayed by 15 minutes.
How has the Titan Medical share price performed this year?
Shares in Titan Medical last closed at $0.03 and the price had moved by -65.89% over the past 365 days. In terms of relative price strength the Titan Medical share price has underperformed the S&P500 Index by -73.38% over the past year.
What are the analyst and broker recommendations for Titan Medical?
The overall consensus recommendation for Titan Medical is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Titan Medical dividend yield?
Titan Medical does not currently pay a dividend.
Does Titan Medical pay a dividend?
Titan Medical does not currently pay a dividend.
When does Titan Medical next pay dividends?
Titan Medical does not currently pay a dividend.
How do I buy Titan Medical shares?
To buy shares in Titan Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Titan Medical?
As of the previous close price of $0.03, shares in Titan Medical had a market capitalisation of $4.14m.
Where are Titan Medical shares listed?
Here are the trading details for Titan Medical:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: TMDIF
What kind of share is Titan Medical?
Based on an overall assessment of its quality, value and momentum Titan Medical is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Titan Medical share price forecast for 2024?
The analyst consensus target price for shares in Titan Medical is $1.98. That is 5618.47% above the last closing price of $0.03.
Analysts covering Titan Medical currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Titan Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Titan Medical. Over the past six months, its share price has underperformed the S&P500 Index by -38%.
As of the last closing price of $0.03, shares in Titan Medical were trading -26.99% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Titan Medical PE Ratio?
The Titan Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Titan Medical?
Titan Medical's management team is headed by:
- Paul Cataford - CHM
- Stephen Lemieux - CFO
- Perry Genova - SVP
- Chien Huang - VFN
- Chris Seibert - VPR
- Kristen Galfetti - VPR
- Tammy Carrea - VPR
- Anthony Giovinazzo - LED
- Heather Knight - IND
- Cary Vance - IND